These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27542210)

  • 41. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
    Lee SB; Kim SH; Bell DW; Wahrer DC; Schiripo TA; Jorczak MM; Sgroi DC; Garber JE; Li FP; Nichols KE; Varley JM; Godwin AK; Shannon KM; Harlow E; Haber DA
    Cancer Res; 2001 Nov; 61(22):8062-7. PubMed ID: 11719428
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Li-Fraumeni syndrome: a paradigm for the understanding of hereditary cancer predisposition.
    Valdez JM; Nichols KE; Kesserwan C
    Br J Haematol; 2017 Feb; 176(4):539-552. PubMed ID: 27984644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.
    Herbert BS; Chanoux RA; Liu Y; Baenziger PH; Goswami CP; McClintick JN; Edenberg HJ; Pennington RE; Lipkin SM; Kopelovich L
    Oncotarget; 2010 Oct; 1(6):405-422. PubMed ID: 21311097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unaffected Li-Fraumeni Syndrome Carrier Parent Demonstrates Allele-Specific mRNA Stabilization of Wild-Type
    Buzby JS; Williams SA; Nugent DJ
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553570
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression profiling identifies three pathways altered in cellular immortalization: interferon, cell cycle, and cytoskeleton.
    Fridman AL; Tang L; Kulaeva OI; Ye B; Li Q; Nahhas F; Roberts PC; Land SJ; Abrams J; Tainsky MA
    J Gerontol A Biol Sci Med Sci; 2006 Sep; 61(9):879-89. PubMed ID: 16960018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TP53, hChk2, and the Li-Fraumeni syndrome.
    Varley J
    Methods Mol Biol; 2003; 222():117-29. PubMed ID: 12710683
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic and functional analysis of a Li Fraumeni syndrome family in China.
    Hu H; Liu J; Liao X; Zhang S; Li H; Lu R; Li X; Lin W; Liu M; Xia Z; Qing G; Li JD
    Sci Rep; 2016 Jan; 6():20221. PubMed ID: 26818906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Germline copy number variation of genes involved in chromatin remodelling in families suggestive of Li-Fraumeni syndrome with brain tumours.
    Aury-Landas J; Bougeard G; Castel H; Hernandez-Vargas H; Drouet A; Latouche JB; Schouft MT; Férec C; Leroux D; Lasset C; Coupier I; Caron O; Herceg Z; Frebourg T; Flaman JM
    Eur J Hum Genet; 2013 Dec; 21(12):1369-76. PubMed ID: 23612572
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell cycle arrest defect in Li-Fraumeni Syndrome: a mechanism of cancer predisposition?
    Williams KJ; Boyle JM; Birch JM; Norton JD; Scott D
    Oncogene; 1997 Jan; 14(3):277-82. PubMed ID: 9018113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations.
    Klein JD; Kupferman ME
    Head Neck; 2017 Feb; 39(2):E20-E22. PubMed ID: 27726232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.
    Ruijs MW; Schmidt MK; Nevanlinna H; Tommiska J; Aittomäki K; Pruntel R; Verhoef S; Van't Veer LJ
    Eur J Hum Genet; 2007 Jan; 15(1):110-4. PubMed ID: 17003841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family.
    Plummer SJ; Santibáñez-Koref M; Kurosaki T; Liao S; Noble B; Fain PR; Anton-Culver H; Casey G
    Oncogene; 1994 Nov; 9(11):3273-80. PubMed ID: 7936651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells.
    Subbaramaiah K; Brown KA; Zahid H; Balmus G; Weiss RS; Herbert BS; Dannenberg AJ
    J Biol Chem; 2016 Jul; 291(31):16011-23. PubMed ID: 27467582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23.
    Bachinski LL; Olufemi SE; Zhou X; Wu CC; Yip L; Shete S; Lozano G; Amos CI; Strong LC; Krahe R
    Cancer Res; 2005 Jan; 65(2):427-31. PubMed ID: 15695383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Atypical fibroxanthoma arising in a young patient with Li-Fraumeni syndrome.
    Lee SM; Zhang W; Fernandez MP
    J Cutan Pathol; 2014 Mar; 41(3):303-7. PubMed ID: 24299451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
    Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
    Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53 Testing for Li-Fraumeni and Li-Fraumeni-like syndromes.
    Gonzalez K; Fong C; Buzin C; Sommer SS; Saldivar JS
    Curr Protoc Hum Genet; 2008 Apr; Chapter 10():Unit 10.10. PubMed ID: 18428420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.